Intra-cellular therapies, inc. (ITCI)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Cash flows used in operating activities
Net loss

-147,722

-155,127

-97,773

-116,426

-104,793

-30,691

-26,868

-16,590

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

477

368

213

196

139

25

23

47

Share-based compensation

20,788

17,396

14,641

14,701

10,890

3,843

391

295

Stock issued for services

194

192

190

233

182

176

-

-

Amortization of premiums and discounts on investment securities, net

1,131

943

-429

-544

-712

-297

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

-

-

-94

63

-20

-284

35

-48

Prepaid expenses and other assets

-1,465

3,026

879

-4,016

6,737

466

574

34

Long term deferred tax asset, net

-264

-529

1,058

-

-

-

-

-

Accounts payable

-6,536

7,787

2,418

2,121

-419

-1,342

3,353

-554

Accrued liabilities and employee benefits

3,327

14,386

1,211

2,147

-3,873

5,065

2,785

-448

Lease liabilities, net

889

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-1,666

-1,666

Deferred rent

-

267

18

1,271

1,597

-

-

-

Net cash used in operating activities

-

-

-

-

-102,279

-22,807

-22,591

-18,902

Net cash used in operating activities

-127,983

-118,169

-80,491

-91,257

-

-

-

-

Cash flows (used in) provided by investing activities
Purchases of investments

80,720

271,156

520,926

395,757

514,308

103,601

-

12,000

Maturities of investments

258,857

406,189

428,932

488,068

153,389

36,879

1,500

17,700

Purchases of property and equipment

700

391

723

48

860

11

33

38

Net cash (used in) provided by investing activities

177,436

134,641

-92,717

92,262

-361,779

-66,734

1,466

5,661

Cash flows provided by financing activities
Proceeds from line of credit

-

-

-

125,000

-

-

-

-

Repayment of line of credit

-

-

-

125,000

-

-

-

-

Proceeds from issuance of convertible promissory notes, net

-

-

-

-

-

-

100

15,163

Proceeds from exercise of stock options

3,235

674

285

477

653

162

332

31

Proceeds from stock subscription

-

-

-

-

-

109

109

-

Proceeds of public offering, net

-

-

162,072

-

449,996

116,191

43,841

-

Proceeds from stock warrant

-

10

-

-

-

-

-

-

Payment of costs of public offerings

-

-

-

-

756

748

3,754

-

Net cash provided by financing activities

3,235

685

162,357

477

449,893

115,715

40,629

15,194

Net increase in cash, cash equivalents, and restricted cash

52,689

17,157

-10,852

1,482

-14,165

26,174

19,505

1,952

Cash paid for interest

-

-

-

36

-

7

11

-

Cash paid for taxes

1

1

1

1,001

-

-

-

13